Skip to main content

Profound Medical Corp.

PROF
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001628808

No open-market purchases or sales by Profound Medical Corp. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $105.8M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Profound Medical Corp. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of PROF: Q2 2024 compared with Q3 2024
MeasureQ2 2024Q3 2024Change
Holders3944+5
Shares9.52M9.42M−101.3K (−1.1%)
Value$80.1M$75.0M−$5.16M (−6.4%)

New holders (9)

Institutions that held Profound Medical Corp. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to PROF in Q3 2024
InstitutionSharesValue% of portfolio
TD Asset Management Inc124,300$989.1K0.00%
Connor, Clark & Lunn Investment Management Ltd.76,900$611.7K0.00%
Renaissance Technologies LLC58,900$468.8K0.00%
Millennium Management LLC53,633$426.9K0.00%
K2 Principal Fund, L.P.50,000$398.0K0.07%
Citadel Advisors LLC26,945$214.5K0.00%
Marshall Wace, LLP12,008$95.6K0.00%
Golden State Equity Partners3,961$31.5K0.00%
IFP Advisors, Inc200$1.59K0.00%

Sold out (4)

Institutions that held Profound Medical Corp. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of PROF in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
AIGH Capital Management LLC646,733$5.44M
UBS Group AG2,361$19.8K
Wetzel Investment Advisors, Inc.2,000$17.1K
Toronto Dominion Bank41$344